Abstract
In the published literature, age, perimenopause and postmenopausal bleeding are the most frequently studied factors for the conversion of endometrial polyps (EPs) to endometrial cancer (EC), also including PCOS and polyp size. Endometrial polypectomy and long-term management may be recommended for these patients.
Introduction
Endometrial polyps (EPs) are a common gynecological condition, affecting up to 35% of women. While the majority of these growths are benign, they carry a significant clinical risk, with approximately 3–5% undergoing malignant transformation into endometrial cancer (EC). Given that EC is a leading cause of gynecological malignancy globally, identifying the specific clinical markers that predict this transformation is a high priority for clinicians. This study utilizes bibliometric analysis to synthesize nearly three decades of research, providing a comprehensive overview of established risk factors and emerging research trends.
Methodology and Data Selection
The researchers conducted a systematic search of the Web of Science Core Collection (WoSCC), targeting original articles published between 1996 and July 2024. After a manual screening process to ensure thematic relevance, 90 core publications were selected for analysis.
To map the scientific landscape, the study employed several specialized tools:
- CiteSpace (V6.1R6): Facilitated co-citation analysis to identify influential authors and institutions.
- R-package "bibliometrix": Used to track keyword frequency and identify "trend topics."
- Document Metrology Platforms: Used to calculate annual publication volumes and national contributions.
Publication Trends and Geographic Landscape
The field of EP-to-EC research is a specialized niche. While the clinical implications are significant, the annual output remains relatively low, typically fewer than 10 articles per year. The volume of research peaked in 2014, followed by a period of fluctuation.
Geographically, the research effort has shifted over time. Spain was an early leader in the field, while Italy has been recognized for the highest level of international cooperation. More recently, China has seen a significant surge in publication volume, particularly since 2019, reflecting a growing regional focus on gynecological oncology.
Established Clinical Risk Factors
The bibliometric synthesis confirms several "gold standard" risk factors that have remained consistent across decades of study:
- Age and Menopausal Status: Women over the age of 60, particularly those in a postmenopausal state, face the highest risk. Data suggests that women in this age bracket are approximately 5.31 times more likely to have malignant polyps than those aged 40–59.
- Abnormal Uterine Bleeding (AUB): Postmenopausal bleeding is one of the most reliable clinical indicators of potential malignancy within a polyp.
- Polyp Size: The analysis identifies a morphological threshold; polyps with a diameter of 18 mm or greater are associated with a significantly higher risk of histological abnormalities.
- Metabolic and Endocrine Factors: There is increasing evidence linking Polycystic Ovary Syndrome (PCOS), obesity (BMI ≥ 32.5), and the use of Tamoxifen (for breast cancer treatment) to higher rates of malignant transformation.
Shifting Research Frontiers
A key finding of this bibliometric study is the evolution of research focus. Prior to 2010, the literature was primarily concerned with identifying and validating individual risk factors. However, recent "trend topic" analysis reveals a pivot toward long-term management and the development of risk prediction models. This suggests the field is maturing from observational studies toward active clinical prevention and personalized patient care strategies.
Limitations and Future Directions
While comprehensive, this analysis is limited by its reliance on a single database (Web of Science), which may exclude relevant studies indexed elsewhere. Additionally, bibliometric methods naturally favor older, highly-cited works, potentially lagging behind the most recent breakthroughs.
The authors note a distinct lack of deep mechanistic studies exploring the molecular pathways of cellular transformation in polyps. Future research should prioritize these biological mechanisms and evaluate the efficacy of long-term interventions, such as the levonorgestrel-releasing intrauterine system, in preventing recurrence and malignancy.
Summary updated